GPBAR1 and colonic neoplasm: Dietary UDCA supplementation, a natural agonist of TGR5, can significantly reduce the incidence of colon cancer through reducing the inflammatory response of colonic mucosa and damage of oxidative stress to cells (Guo et al., 2023; He et al., 2023).